ArticleIJTLD open2024
Perspectives from the 2
Abstract read
In one paragraph
Article in IJTLD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Post-Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management.MedComm · 2026Review
- Elimination of senescent cells with senolytic drugs as adjunctive host-directed therapy reduces tuberculosis progression in mice.Nature communications · 2026Article
- Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT.Diseases (Basel, Switzerland) · 2026Article
- Rehabilitation for individuals with post-tuberculosis lung disease.Breathe (Sheffield, England) · 2026Review
- Article
- Multimorbidity and health-related quality of life after tuberculosis treatment in Zimbabwe: A cross-sectional study with household comparators.PLOS global public health · 2026Article
- Long-term mortality and cause of death in people with tuberculosis compared with matched controls with influenza or non-typhoid salmonellosis in Australia: a retrospective cohort study.BMJ public health · 2026Article
- Mapping the research, policy, and clinical management landscape of post-tuberculosis lung disease: A scoping review.PLOS global public health · 2026Article
- Mortality hazards after treatment completion of pulmonary tuberculosis in a tertiary hospital in Uganda.IJID regions · 2025Article
- Post-TB treatment completion experiences of children, adolescents, and caregivers from Cape Town.IJTLD open · 2025Article
- Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions.European respiratory review : an official journal of the European Respiratory Society · 2025Review
- Lung function trajectories in children with pulmonary TB and non-TB lower respiratory tract infections.IJTLD open · 2025Article
- Community-based pulmonary rehabilitation for post-TB lung disease - a programmatic intervention.IJTLD open · 2025Article
- A longitudinal analysis of the economic cost of all phases of TB care in a low incidence setting.IJTLD open · 2025Article
- Article
- Post-TB sequelae and care: a systematic review and synthesis of qualitative research.IJTLD open · 2025Article
- Pulmonary rehabilitation for post-TB lung disease led by TB survivors.Public health action · 2025Article
- Post-tuberculosis lung disease: towards prevention, diagnosis, and care.The Lancet. Respiratory medicine · 2025Review
- Article
- The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study.BMC pulmonary medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
B W AllwoodDivision of Pulmonology, Department of Medicine, Faculty of Medicine, Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
R NightingaleDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool.
G AgbotaUniversity of Montpellier, Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), Institut de recherche pour le Developpement (IRD), Institut National de la Sante et de la Recherche Médicale (INSERM), Montpellier, France.
S AuldDepartments of Medicine, Epidemiology, and Global Health, Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA.
G P BissonDepartments of Medicine and Biostatistics, Epidemiology, and Informatics, Division of Infectious Diseases and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
A ByrneThoracic Medicine Division of the Heart Lung Stream of St Vincent's Hospital Sydney Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
R DunnDivision of Orthopaedic Surgery, Groote Schuur Hospital, Cape Town.
D EvansHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg.
G HoddinottDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
G GüntherDepartment of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Z IslamAlliance for Public Health, Kyiv, Ukraine.
J C JohnstonUniversity of British Columbia, Vancouver, BC, Canada.
G KalyatandaDivision of Infectious Disease and Global Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
C KhosaInstituto Nacional de Saúde, Marracuene, Mozambique.
S MaraisDivision of Neurology, Department of Medicine, University of Cape Town & Neurology Research Group, Neuroscience Institute, University of Cape Town, Cape Town.
G MakandaTB Proof, Cape Town, South Africa.
O M MashediKenya Medical Research Institute, Centre for Respiratory Diseases Research, Nairobi, Kenya.
J MeghjiNational Heart & Lung Institute, Imperial College London, London, UK.
C MitnickProgram in Infectious Disease and Social Change, Harvard Medical School, Boston, MA, USA.
C MulderDivision TB Elimination and Health System Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands.
E NkereuwemVaccines and Immunity Theme, MRC (Medical Research Council) Unit The Gambia at The London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, The Gambia.
O NkereuwemVaccines and Immunity Theme, MRC (Medical Research Council) Unit The Gambia at The London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, The Gambia.
O B OzohDepartment of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
A RachowDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany.
K RomanowskiUniversity of British Columbia, Vancouver, BC, Canada.
J A SeddonDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
I SchoemanTB Proof, Cape Town, South Africa.
F ThienemannGeneral Medicine & Global Health (GMGH), Department of Medicine & Cape Heart Institute, University of Cape Town, South Africa.
N F WalkerDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool.
D T WademanDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
R WallisDepartment of Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, USA.
M M van der ZalmDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Funding
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8MThe long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African childrenK43TW011028 · FIC · STELLENBOSCH UNIVERSITY · PI VAN DER ZALM, MARIEKE MARGREET · 2020 to 2024
$647kFIC NIH HHS K43 TW011028Medical Research Council MR/S02042X/1NIAID NIH HHS P30 AI168386
Abstract
In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2
Indexed as
advocacypost-tuberculosisproceedingsresearchSymposium
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.